Research theme for competitive and other funds (8):
2022 - 2025 Predicting the effect of graft-versus-leukemia (GVL) effect for refractory hematological malignancy
2023 - 2025 The evaluation of measurable residual disease and clonal evolution of resistant clone in the novel phase 2 trial of allogeneic hematopoietic cell transplantation following total marrow and lymphoid irradiation.